Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding Curis Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CRIS: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6159−2
Shares28.7M29.8M+1.14M (+4.0%)
Value$17.1M$24.7M+$7.65M (+44.8%)

New holders (5)

Institutions that held Curis Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CRIS in Q2 2023
InstitutionSharesValue% of portfolio
Two Sigma Securities, LLC21,864$18.1K0.00%
National Asset Management, Inc.11,240$9.33K0.00%
Virtu Financial LLC10,455$9.00K0.00%
Rhumbline Advisers2,882$2.39K0.00%
Newbridge Financial Services Group, Inc.1,000$8300.00%

Sold out (7)

Institutions that held Curis Inc at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of CRIS in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Nantahala Capital Management, LLC230,614$137.4K
The PNC Financial Services Group, Inc.60,291$35.9K
Jane Street Group, LLC28,542$17.0K
Susquehanna International Group, LLP23,966$14.3K
Connor, Clark & Lunn Investment Management Ltd.11,463$6.83K
Victory Capital Management Inc10,152$6.05K
Belpointe Asset Management LLC5,635$3.36K